Optimal Flu Vaccination Timing: Late September to October Recommended

Israel has launched its annual flu vaccination campaign for the 2026-2027 season, with vaccines being distributed to clinics starting in early September. While the goal is to achieve immunity before the flu season intensifies, experts advise against vaccinating too early, as the protection can wane over several months. The ideal window for most adults to get vaccinated is late September and October. This timing allows the immune system sufficient time to develop protection before the anticipated rise in influenza cases, while ensuring the vaccine's effectiveness extends through the winter months.

Influenza activity typically increases in the fall, peaks in winter, and can persist into spring, with the exact timing and severity varying annually. The Centers for Disease Control and Prevention in the U.S. also recommends September and October as suitable months for vaccination. The primary objective is to be vaccinated before flu spread becomes widespread, but not so early that immunity diminishes before the season concludes.

Annual vaccination is necessary because the flu vaccine's composition is updated each year to match predicted prevalent strains, and the immune protection it provides naturally decreases over time. While the vaccine does not guarantee complete prevention of infection, it significantly reduces the risk of severe illness, complications, and hospitalization. Flu can lead to serious health issues, including pneumonia, especially for vulnerable populations such as the elderly, infants, pregnant women, and individuals with chronic conditions.

Certain groups, including those aged 65 and older, individuals with chronic illnesses, pregnant women, young children, people with obesity, healthcare workers, and residents of closed institutions, are particularly encouraged to get vaccinated. Children under eight requiring two doses should also be vaccinated early to complete the series before the season peaks. However, even if the optimal window is missed, vaccination in November, December, or later in the winter still offers benefits as long as the virus is circulating.

This year's vaccines in Israel are quadrivalent, targeting four predicted strains. The most common is an inactivated vaccine given by injection, approved for ages six months and up. A live attenuated nasal spray vaccine is available for individuals aged two to 49, subject to medical conditions. Some individuals aged 65 and older or those at high risk may be eligible for a high-dose vaccine. It is advisable to consult with a clinic to determine the most suitable and available vaccine.